Effects of flavonoids on senescence-associated secretory phenotype formation from bleomycin-induced senescence in BJ fibroblasts

Biochemical Pharmacology

Volumn 96, Issue 4, 2015, Pages 337-348

  Lim, Hyun ^a   Park, Haeil ^a   Kim, Hyun Pyo ^a  

^a Kangwon National University   (South Korea)

Author keywords

Chronic low grade inflammation; Flavonoid; I B ; SASP; Senescence

Indexed keywords

BLEOMYCIN; CCL8 PROTEIN, HUMAN; CXCL1 CHEMOKINE; FLAVONOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; I KAPPA B; INTERLEUKIN DERIVATIVE; MONOCYTE CHEMOTACTIC PROTEIN 2; NFKBIZ PROTEIN, HUMAN; NUCLEAR PROTEIN; STROMELYSIN;

AGING; ANIMAL; CELL AGING; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; HUMAN; KIDNEY; MALE; METABOLISM; SPRAGUE DAWLEY RAT; STRUCTURE ACTIVITY RELATION;

AGING; ANIMALS; BLEOMYCIN; CELL AGING; CELL LINE; CHEMOKINE CCL8; CHEMOKINE CXCL1; FIBROBLASTS; FLAVONOIDS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; I-KAPPA B PROTEINS; INTERLEUKINS; KIDNEY; MALE; MATRIX METALLOPROTEINASE 3; NUCLEAR PROTEINS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84938291358     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2015.06.013     Document Type: Article

References (44)

1. L. Hayflick The limited in vitro lifetime of human diploid cell strains Exp. Cell Res. 37 1965 614 636
2. J. Campisi Aging, cellular senescence, and cancer Annu. Rev. Physiol. 75 2013 685 705
3. F. Rodier, and J. Campisi Four faces of cellular senescence J. Cell Biol. 192 2011 547 556
4. M. Kumar, W. Seeger, and R. Voswinckel Senescence-associated secretory phenotype and its possible role in chronic obstructive pulmonary disease Am. J. Respir. Cell Mol. Biol. 51 2014 323 333
5. Y. Zhu, J.L. Armstrong, T. Tchkonia, and J.L. Kirkland Cellular senescence and the senescent secretory phenotype in age-related chronic diseases Curr. Opin. Clin. Nutr. Metab. Care 17 2014 324 328
6. J. Campisi, J.K. Andersen, P. Kapahi, and S. Melov Cellular senescence: a link between cancer and age-related degenerative disease? Semin. Cancer Biol. 21 2011 354 359
7. A. Onat, and G. Can Enhanced proinflammatory state and autoimmune activation: a breakthrough to understanding chronic diseases Curr. Pharm. Des. 20 2014 575 584
8. A. Freund, C. Patil, K. Age, and J. Campisi p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype EMBO J. 30 2011 1536 1548
9. A. Salminen, A. Kauppinen, and K. Kaarniranta Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP) Cell. Signal. 24 2012 835 845
10. P. Wang, L. Han, H. Shen, P. Wang, C. Lv, G. Zhao, and et al. Protein kinase D1 is essential for Ras-induced senescence and tumor suppression by regulating senescence-associated inflammation Proc. Natl. Acad. Sci. U. S. A. 111 2014 7683 7688
11. Y. Chien, C. Scuoppo, X. Wang, X. Fang, B. Balgley, J.E. Bolden, and et al. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity Genes Dev. 25 2011 2125 2136
12. A.V. Orjalo, D. Bhaumik, B.K. Gengler, G.K. Scott, and J. Campisi Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network Proc. Natl. Acad. Sci. U. S. A. 106 2009 17031 17036
13. C.J. Huggins, R. Malik, S. Lee, J. Salotti, S. Thomas, N. Martin, and et al. C/EBPγ suppresses senescence and inflammatory gene expression by heterodimerizing with C/EBPβ Mol. Cell. Biol. 33 2013 3242 3258
14. E. Alexander, D.G. Hildebrand, A. Kriebs, K. Obermayer, M. Manz, O. Rothfuss, and et al. IκBζ is a regulator of the senescence-associated secretory phenotype in DNA damage- and oncogene-induced senescence J. Cell Sci. 126 2013 3738 3745
15. M. Motoyama, S. Yamazaki, A. Eto-Kimura, K. Takeshige, and T. Muta Positive and negative regulation of nuclear factor-κB-mediated transcription by IκB-ζ, an inducible nuclear protein J. Biol. Chem. 280 2005 7444 7451
16. D.G. Hildebrand, E. Alexander, S. Hörber, S. Lehle, K. Obermayer, N.A. Münck, and et al. IκBζ is a transcriptional key regulator of CCL2/MCP-1 J. Immunol. 190 2013 4812 4820
17. S. Matsuo, S. Yamazaki, K. Takeshige, and T. Muta Crucial roles of binding sites for NF-κB and C/EBPs in IκB-ζ-mediated transcriptional activation Biochem. J. 405 2007 605 615
18. E. Middleton Jr., C. Kandaswami, and T.C. Theoharides The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer Pharmacol. Rev. 52 2000 673 751
19. L. Ding, D. Jin, and X. Chen Luteolin enhances insulin sensitivity via activation of PPARγ transcriptional activity in adipocytes J. Nutr. Biochem. 21 2010 941 947
20. A. Csiszar, D. Sosnowska, M. Wang, E.G. Lakatta, W.E. Sonntag, and Z. Ungvari Age-associated proinflammatory secretory phenotype in vascular smooth muscle cells from the non-human primate Macaca mulatta: reversal by resveratrol treatment J. Gerontol. A: Biol. Sci. Med. Sci. 67 2012 811 820
21. H.P. Kim, K.H. Son, H.W. Chang, and S.S. Kang Anti-inflammatory plant flavonoids and cellular action mechanisms J. Pharmacol. Sci. 96 2004 229 245
22. V. Pitozzi, A. Mocali, A. Laurenzana, E. Giannoni, I. Cifola, C. Battaglia, and et al. Chronic resveratrol treatment ameliorates cell adhesion and mitigates the inflammatory phenotype in senescent human fibroblasts J. Gerontol. A: Biol. Sci. Med. Sci. 68 2013 371 381
23. J.M. Kim, E.K. Lee, D.H. Kim, B.P. Yu, and H.Y. Chung Kaempferol modulates pro-inflammatory NF-κB activation by suppressing advanced glycation endproducts-induced NADPH oxidase Age (Dordr.) 32 2010 197 208
24. H.A. Lim, E.K. Lee, J.M. Kim, M.H. Park, D.H. Kim, Y.J. Choi, and et al. PPARγ activation by baicalin suppresses NF-κB-mediated inflammation in aged rat kidney Biogerontology 13 2012 133 145
25. K.M. You, H.G. Jong, and H.P. Kim Inhibition of cyclooxygenase/lipoxygenase from human platelets by polyhydroxylated/methoxylated flavonoids isolated from medicinal plants Arch. Pharm. Res. 22 1999 18 24
26. T.T. Dao, Y.S. Chi, J. Kim, H.P. Kim, S. Kim, and H. Park Synthesis and PGE2 inhibitory activity of 5,7-dihydroxyflavones and their O-methylated flavone analogs Arch. Pharm. Res. 26 2003 345 350
27. H. Che, H. Lim, H.P. Kim, and H. Park A chrysin analog exhibited strong inhibitory activities against both PGE2 and NO production Eur. J. Med. Chem. 46 2011 4657 4660
28. R.M. Laberge, L. Zhou, M.R. Sarantos, F. Rodier, A. Freund, P.L. de Keizer, and et al. Glucocorticoids suppress selected components of the senescence-associated secretory phenotype Aging Cell 11 2012 569 578
29. J.H. Lee, H. Lim, O. Shehzad, Y.S. Kim, and H.P. Kim Ginsenosides from Korean red ginseng inhibit matrix metalloproteinase-13 expression in articular chondrocytes and prevent cartilage degradation Eur. J. Pharmacol. 724 2014 145 151
30. C. Canino, F. Mori, A. Cambria, A. Diamantini, S. Germoni, G. Alessandrini, and et al. SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells Oncogene 31 2012 3148 3163
31. C.K. Han, M.J. Son, H.W. Chang, Y.S. Chi, H. Park, and H.P. Kim Inhibition of prostaglandin production by a structurally-optimized flavonoid derivative, 2′,4′,7-trimethoxyflavone and cellular action mechanism Biol. Pharm. Bull. 28 2005 1366 1370
32. H. Lim, J.H. Jin, H. Park, and H.P. Kim New synthetic anti-inflammatory chrysin analog, 5,7-dihydroxy-8-(pyridine-4yl)flavone Eur. J. Pharmacol. 670 2011 617 622
33. F. Rodier, J.P. Coppé, C.K. Patil, W.A. Hoeijmakers, D.P. Muñoz, S.R. Raza, and et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion Nat. Cell Biol. 11 2009 973 979
34. O. Moiseeva, X. Deschênes-Simard, E. St-Germain, S. Igelmann, G. Huot, A.E. Cadar, and et al. Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation Aging Cell 12 2013 489 498
35. Z. Wu, X. Zhang, J. Yang, G. Wu, Y. Zhang, Y. Yuan, and et al. Nuclear protein IκB-ζ inhibits the activity of STAT3 Biochem. Biophys. Res. Commun. 387 2009 348 352
36. T. Ohba, Y. Ariga, T. Maruyama, N.K. Truong, J. Inoue, and T. Muta Identification of interleukin-1 receptor-associated kinase 1 as a critical component that induces post-transcriptional activation of IκB-ζ FEBS J. 279 2012 211 222
37. J.A. Baur, K.J. Pearson, N.L. Price, H.A. Jamieson, C. Lerin, A. Kalra, and et al. Resveratrol improves health and survival of mice on a high-calorie diet Nature 444 2006 337 342
38. J.G. Wood, B. Rogina, S. Lavu, K. Howitz, S.L. Helfand, M. Tatar, and et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans Nature 430 2004 686 689
39. M.J. Park, E.K. Lee, H.S. Heo, M.S. Kim, B. Sung, M.K. Kim, and et al. The anti-inflammatory effect of kaempferol in aged kidney tissues: the involvement of nuclear factor-κB via nuclear factor-inducing kinase/IκB kinase and mitogen-activated protein kinase pathways J. Med. Food 12 2009 351 358
40. M.L. Neuhouser Dietary flavonoids and cancer risk: evidence from human population studies Nutr. Cancer 50 2004 1 7
41. M.L. McCullough, J.J. Peterson, R. Patel, P.F. Jacques, R. Shah, and J.T. Dwyer Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults Am. J. Clin. Nutr. 95 2012 454 464
42. P. Knekt, R. Järvinen, R. Seppänen, M. Hellövaara, L. Teppo, E. Pukkala, and et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms Am. J. Epidemiol. 146 1997 223 230
43. M.G. Hertog, E.J. Feskens, P.C. Hollman, M.B. Katan, and D. Kromhout Dietary flavonoids and cancer risk in the Zutphen Elderly Study Nutr. Cancer 22 1994 175 184
44. P.F. Jacques, A. Cassidy, G. Rogers, J.J. Peterson, J.B. Meigs, and J.T. Dwyer Higher dietary flavonol intake is associated with lower incidence of type 2 diabetes J. Nutr. 143 2013 1474 1480